Correlation Between Apogee Therapeutics, and Integral

Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Integral at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Integral into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apogee Therapeutics, Common and Integral Ad Science, you can compare the effects of market volatilities on Apogee Therapeutics, and Integral and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Integral. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Integral.

Diversification Opportunities for Apogee Therapeutics, and Integral

0.29

Correlation Coefficient

Apogee Therapeutics,  Integral

Modest diversification

The 3 months correlation between Apogee and Integral is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Integral Ad Science in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integral Ad Science and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Integral. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integral Ad Science has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Integral go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and Integral

Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to under-perform the Integral. In addition to that, Apogee Therapeutics, is 1.45 times more volatile than Integral Ad Science. It trades about -0.03 of its total potential returns per unit of risk. Integral Ad Science is currently generating about -0.01 per unit of volatility. If you would invest  1,100  in Integral Ad Science on September 17, 2024 and sell it today you would lose (42.00) from holding Integral Ad Science or give up 3.82% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Apogee Therapeutics, Common  vs.  Integral Ad Science

Apogee Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Integral Ad Science

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Integral Ad Science has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Integral is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Apogee Therapeutics, and Integral

The main advantage of trading using opposite Apogee Therapeutics, and Integral positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Integral can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integral will offset losses from the drop in Integral's long position.

The idea behind Apogee Therapeutics, Common and Integral Ad Science pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.